Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience  by Ersche, Karen D et al.
Meta-analysis of structural brain abnormalities associated with
stimulant drug dependence and neuroimaging of addiction
vulnerability and resilience
Karen D Ersche1, Guy B Williams1,2, Trevor W Robbins1 and
Edward T Bullmore1,3,4
Available online at www.sciencedirect.comSince the first study in stimulant-dependent individuals using
structural MRI was published fifteen years ago, much evidence
has accumulated on brain abnormalities associated with
stimulant drug dependence. Here we conducted a voxel-based
morphometry meta-analysis of published MRI data in
stimulant-dependent individuals to clarify the most robust
abnormalities underlying the disorder. We found that
neuroimaging studies in stimulant-dependent individuals
consistently report a gray matter decline in the prefrontal cortex
regions associated with self-regulation and self-awareness.
One of the next key questions that neuroimaging research
today needs to address is the question of causality, namely to
what extent these brain abnormalities are caused by the toxic
effects of drug exposure, or the possibility that these may have
predated drug-taking and even predisposed individuals for the
development of drug dependence. Although the question of
causality has not yet been answered completely, there has
been significant progress made to date.
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Introduction
The United Nations estimates that one in every 200
people worldwide is affected by drug use problems
[1], which in turn creates enormous costs for the
affected individuals, their families, communities and
society as a whole. An escalation in the adverse con-
sequences of drug abuse, both personal and societal,
necessitates the improvement of treatment options for
Open access under CC BY-NC-ND license.www.sciencedirect.com people whose drug use has become problematic. Stimu-
lant drugs such as cocaine and amphetamines are popular
recreational drugs, but their chronic use can result in
significant harm [2], and, most worryingly, dependence
on stimulant drugs is still difficult to treat [3]. A better
understanding of the neuropathology underlying the
clinical symptoms of stimulant dependence may help
to identify new targets for interventions; and the marked
increase in neuroimaging studies over the past few years
has partly been fuelled by this pressing need for the
development of more efficient treatments for stimu-
lant-dependent individuals [4].
The majority of published neuroimaging studies report
significant structural abnormalities within fronto-striatal
brain systems in stimulant-dependent individuals. This
anatomical profile appears plausible given that the core
clinical symptoms of addiction, the loss of control over
drug use and the compulsive nature in which drugs are
consumed, are known to be subserved by fronto-striatal
neural networks [5]. However, the knowledge gained
from these neuroimaging studies in stimulant depen-
dence has not yet been translated into better treatments.
One reason for this might be that the structural abnorm-
alities identified across studies have been relatively
inconsistent. For example, several studies reported sig-
nificant enlargement of the basal ganglia in stimulant-
dependent individuals [6–10], while others found a sig-
nificant reduction in basal ganglia volume in these
patients [11–13], and two studies could not identify
any structural abnormalities in cocaine-dependent indi-
viduals at all [14,15]. Another reason may be the lack of
clarity about the extent to which the observed neurobio-
logical abnormalities in stimulant-dependent individuals
are caused by the toxic effects of drug exposure, and
whether these are potentially reversible. It is also con-
ceivable that the observed abnormalities are not caused
by drug exposure, but instead may have predated drug-
taking, rendering individuals vulnerable for dependence.
Further clarification of the health risks associated with
stimulant abuse would help to improve therapeutic strat-
egies for prevention and treatment in the future.
In this review, we aim to discuss this basic question of
causality with regard to structural brain abnormalities
associated with stimulant drug dependence. In order to
determine the most robust brain abnormalities associatedCurrent Opinion in Neurobiology 2013, 23:615–624
616 Addictionwith stimulant drug dependence, we performed a voxel-
based meta-analysis of the structural neuroimaging stu-
dies. For this analysis, we aimed to be comprehensive and
inclusive without restricting publication dates, but in the
discussion we will focus on the most recent developments
in the field.
Meta-analysis of structural abnormalities in
stimulant drug dependence
We searched the scientific databases of PubMed, Web of
Knowledge and Science Direct for neuroimaging studies
comparing individuals with chronic stimulant use and
matched healthy control volunteers using the terms:
voxel-based morphometry (VBM), structural magnetic
resonance imaging (MRI), brain, cocaine, amphetamines,
methamphetamine, stimulants. We only included studies
that contained original data in a complete article (not
abstracts), used voxel-based morphometry for the analysis
of structural MRI brain scans, and analyzed the whole
brain. We excluded studies in which individuals did not
satisfy the diagnostic criteria for cocaine, amphetamine or
methamphetamine dependence according to DSM-IV.
On the basis of these criteria, we identified 16 studies
suitable for the meta-analysis, listed in Table 1. Two
further studies did not identify any significant structural
differences between cases and controls [14,15].
The meta-analysis of regional gray matter differences was
performed using GingerALE software [16]. Co-ordinates
reported in Montreal Neurological Institute format were
converted to Talairach stereotactic space [17]. Probability
maps were generated and thresholded, controlling the
False Discovery Rate (FDR) at q < 0.01. The minimum
cluster size was set at 25 voxels. MRIcron software [18]
was used to visualize brain areas with significantly altered
gray matter on an MRI template image. The effect of
duration of stimulant drug use was also assessed by meta-
regression using SDM software (http://www.sdmproject.-
com) [19].
The sample for the voxel-based meta-analysis comprised
494 stimulant-dependent individuals and 428 healthy
control volunteers. The mean sample size across the 14
studies that provided data was 32 for stimulant-depend-
ent individuals and 34 for control volunteers. The
majority of participants were male (79% stimulant group;
69% control group). Overall there were no significant age
differences between the groups (t = 1.81, P = 0.82) with
a mean age of 35.6 years. As shown in Table 1, the average
duration of stimulant use was 12.1 years (4.5 standard
deviations) and in four of the 14 studies patients were
drug abstinent for more than one month at the time of
scanning.
For the meta-analysis of gray matter decreases in patients
compared to controls there were 62 sets of coordinatesCurrent Opinion in Neurobiology 2013, 23:615–624 included from the primary studies; for the meta-analysis
of gray matter increases in patients there were seven sets
of coordinates included from the primary literature. One
study compared two cocaine groups with the same control
group [11], and so the cocaine abstinent subgroup was
excluded from the analysis to avoid overlapping sub-
groups.
The meta-analysis revealed significant decreases in gray
matter in stimulant-dependent individuals in five regions:
the insula, ventromedial prefrontal cortex, inferior frontal
gyrus, pregenual anterior cingulate gyrus, and anterior
thalamus (for details see Table 2 and Figure 1). No
regions of gray matter increases in patients were signifi-
cant.
The identified areas of gray matter decreases were part of
a neural network previously implicated in the processing
of drug-related cues [20], and more generally in the
regulation of emotional, cognitive and behavioral
responses. For example, the anterior cingulate gyrus, in
concert with the insula and the right inferior frontal gyrus
plays an important role in the awareness of cognitive,
affective and physical states [21]. The right inferior
frontal gyrus is critically implicated in inhibitory response
control functions [22] while the ventromedial prefrontal/
orbitofrontal cortex is specifically concerned with the
assessment of value and the evaluation of outcomes
associated with behavioral choices [23,24]. Given that
the prefrontal cortex, partly through cortico-striatal cir-
cuitries, influences many aspects of human behavior,
dysfunction typically manifests as poor decision-making
and maladaptive behavior, traits which are frequently
observed in people with stimulant drug dependence
[25,26,27]. Insufficient top-down control from the pre-
frontal cortex may also lead to a predominance of habitual
behaviors, which are mediated by dorsolateral parts of the
striatum (putamen) [28]. In the context of drug use, such
an imbalance between top-down and bottom-up control
may result in deleterious consequences, as drug-taking
habits are decoupled from the regulatory influences of the
prefrontal cortex.
The brain abnormalities identified by this meta-analysis
in prefrontal brain regions concur well with the perfusion
and metabolic alterations frequently described in stimu-
lant-dependent individuals [29,30]. However, our
analysis did not detect abnormalities in basal ganglia
structures. At first glance, this may seem surprising in
light of the close interconnections between the prefrontal
cortex, the striatum and the compulsive patterns of drug-
taking which are a hallmark of addiction. Yet, there are a
number of plausible reasons that may account for the lack
of striatal abnormalities identified in this meta-analysis.
The most obvious reason lies in the inconsistencies in
the directions of reported striatal change in the primary
literature. Thus in the search for commonalities inwww.sciencedirect.com
B
ra
in
 a
b
n
o
rm
a
litie
s
 in
 s
tim
u
la
n
t
 d
ru
g
 d
e
p
e
n
d
e
n
c
e
 E
rs
c
h
e
 e
t
 a
l.
 
6
1
7
Table 1
Details about the studies considered for the meta-analysis in alphabetical order. Although the studies by Narayana et al. [14] and Weller et al. [15] met criteria for inclusion, they did not
identify significant group differences between cases and controls at whole brain level, and were thus not included in analysis.
Authors Sample size (N) Males (%) Mean age (SD) Diagnosis Years of use (SD) Duration of
abstinence
Patients Controls Patients Controls Patients Controls
Alia-Klein et al. [61] 40 42 100 100 45 (6.3) 39 (6.5) Cocaine dependence 19.0 (1.4) Not abstinent
Barros-Loscertales
et al. [12]
20 16 100 100 33.3 (6.4) 33.4 (9.2) Cocaine dependence 13.2 (6.0) >4 days
Ersche et al. [8] 60 60 88 77 32.5 (8.5) 32.3 (8.3) Cocaine dependence 10.0 (7.1) Not abstinent
Ersche et al. [37] 47 50 92 64 34.5 (7.4) 32.8 (8.9) Cocaine dependence (94%)
Amphetamine dependence (6%)
16.3 (7.6) Not abstinent
Franklin et al. [62] 13 16 – – 42 (6.3) 32 (6.9) Cocaine dependence 13.0 (6.5) Not reported
Hanlon et al. [11] 24
25
71
48
38.9 (0.9)
36.2 (1.0) Cocaine dependence 11.1 (1.2) Not abstinent
24 63 37.0 (1.5) Cocaine dependence 10.2 (1.5) 1.5–8 months
Jan et al. [9] 17 20 71 65 35.1 (6.6) 30.9 (8.2) Methamphetamine dependence 10.2 (5.8) Not abstinent
Kim et al. [63] 29 20 93 75 36.75 33.2 (6.5) Methamphetamine dependence 5.4 (3.7) >4 weeks
Morales et al. [64] 39 43 51 49 34.8 (1.5) 32.8 Methamphetamine dependence 11.5 (1.5) 4–7 days
Moreno-Lopez et al. [13] 38 38 100 100 29.6 (6.5) 31.1 (5.1) Cocaine dependence 4.1 (3.1) >1 month
Narayana et al. [14] 29 29 72 72 41.0 (9.1) 34.3 (10.2) Cocaine dependence 12.7 (7.7) Not abstinent
Parvaz et al. [65] 22 17 82 59 42.9 (6.2) 40.3 (6.7) Cocaine dependence (82%)
Cocaine abuse (18%)
17.8 (6.9) 4.5 days
Schwartz et al. [66] 44 61 68 51 33.4 (8.4) 34.1 (10.7) Methamphetamine dependence Not reported >2 weeks
Sim et al. [67] 40 41 67 63 41.4 (6.9) 38.7 (8.8) Cocaine dependence 15.3 (6.2) Not reported
Tanabe et al. (2009) [68] 19 20 53 30 35 (7) 33 (11) Cocaine dependence (73%)
Amphetamine dependence (63%)
Cocaine abuse or amphetamine
abuse (15%)
Not reported >2 years
Weller et al. [15] 9 8 100 100 41.0 (5.7) 39.5 (5.4) Cocaine dependence Not reported 1–19 days
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Table 2
Locations of abnormally reduced gray matter volume in chronic users of cocaine and amphetamines compared to healthy volunteers;
identified by meta-analysis of 14 MRI studies in the primary literature.
Cluster Volume (mm3) Weighted centre (x, y, z) P-value x y z Anatomical label
1 416 42.46 6.56 0.18 0.015312 42 10 0 Left insula
Brodmann area 13
0.011523 42 0 2 Left insula
Brodmann area 13
2 232 6.03 1.65 5.29 0.014608 6 2 6 Left thalamus
Anterior nucleus
3 184 20.03 23.99 9.97 0.014043 20 24 10 Left middle frontal gyrus
Brodmann area 11
4 104 5.23 46.35 7.65 0.012401 6 46 8 Right anterior cingulate
Brodmann area 32
5 88 25.1 22.91 9.09 0.010912 26 24 10 Right inferior frontal gyrus
Brodmann area 47
0.010637 26 20 8 Brodmann area 13published case-control comparisons, studies with
increased and decreased striatal volume (e.g., [9,11])
may have simply negated each other in the meta-analysis.
It is also conceivable that subcortical abnormalities in
stimulant-dependent individuals are not so reliably
measured by computational techniques as the cortical
changes, and therefore may not be captured by VBM
techniques. Indeed, several studies reporting striatal
enlargement in stimulant-dependent individuals used
manual or semi-automatic volumetry [6,7,10], not
VBM, and were thus not included in our analysis. It is
also of note that volume increase in the striatum has
frequently been reported in both animal and humans
following blockade of dopamine D2 receptors by anti-
psychotic drugs [31–35]; and methylphenidate has shown
to normalize the reduced striatal volume in children with
ADHD [36]. One may speculate as to whether volume
changes in the striatum of stimulant-dependent individ-
uals are particularly susceptible to individual differences
in the recent history of stimulant abuse (or abstinence)
compared with the changes observed in cortical brain
regions. Finally, one also needs to bear in mind that
healthy volunteers in most of the published studies were
not selected on the basis of their family histories, that is, itTable 3
Positive and negative correlations between the years of stimulant dru
Positive correlations (clusters of 10 voxels with a
Talairach Z P 
22, 8, 18 2.308 0.000012845 
Negative correlations (clusters of 10 voxels with al
Talairach Z P 
24, 26, 12 2.429 0.000064226 
36, 16, 30 1.954 0.001130379 
32, 16, 12 1.905 0.001323057 
Current Opinion in Neurobiology 2013, 23:615–624 is possible that some healthy control volunteers have a
family history of addiction and thus share with the de-
pendent group the enlargement of the putamen, amyg-
dala and hippocampus that has been reported in first-
degree relatives of people with stimulant dependence
[37]. Consequently, the absence of these limbic-striatal
abnormalities in stimulant-dependent individuals in this
meta-analysis should be considered with caution.
We further conducted a meta-regression to identify which
of the abnormal brain regions were associated with the
duration of stimulant use. As shown in Table 3, the longer
the individuals had been using stimulants, the greater the
decline in gray matter in the inferior and frontal middle
frontal gyri. Conversely, gray matter volume in the para-
hippocampal gyrus appeared to be differentially related to
the duration of stimulant use, with the left parahippo-
campal gyrus being associated with an increase in volume
the longer individuals had been using stimulants, whilst
the right parahippocampal gyrus showed the opposite
relationship. In light of the important roles of the frontal
cortex and the limbic system in the development of
addiction, the relationship between the changes in their
structure and the duration of stimulant abuse seemsg use and gray matter volume.
ll voxels Z  1.214 and peak voxel Z  1.000)
Voxels Description
361 Left parahippocampal gyrus
l voxels Z  1.555 and peak voxel Z  1.000)
Voxels Description
114 Left inferior frontal gyrus, Brodmann area 11
16 Right middle frontal gyrus, Brodmann area 9
28 Right parahippocampal gyrus
www.sciencedirect.com
Brain abnormalities in stimulant drug dependence Ersche et al. 619
Figure 1
(a)
(b)
-10 -7 -1
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Reduction in gray matter volume in stimulant-dependent individuals (controlling the False Discovery Rate at q < 0.01), as identified by the meta-
analysis shown (a) on a rendering of the cortical surface, and (b) in axial slices. The left side of the brain is shown on the left side of each slice; the blue
numbers denote z-coordinates for each slice in Talairach stereotactic space.
www.sciencedirect.com Current Opinion in Neurobiology 2013, 23:615–624
620 Addictionplausible. However, in order to discuss these changes in
view of the chicken and egg question, additional approaches
would be necessary.
The ‘chicken-and-egg’ dilemma
The question as to whether the neurobiological abnorm-
alities frequently observed in stimulant-dependent indi-
viduals reflect a predisposing cause for their addiction, or
an effect of their long-term exposure to potentially
neurotoxic drugs, is difficult to address in human drug
addiction research. In clinical settings, there are a grow-
ing number of studies investigating the long-term effects
on structural brain development in children who have
been prenatally exposed to stimulant drugs. However, as
in the adult literature, the results regarding structural
brain abnormalities are largely inconsistent [38–40]; but
once more data are available, meta-analyses may bring
clarity.
A more promising strategy for disentangling the predis-
posing causes from the stimulant-related effects is a
search for vulnerability markers. Endophenotypes have
been defined as measurable traits that mediate between
the predisposing genes (genotypes) and the clinical symp-
toms (phenotype) [41]. As brain structure has been shown
to be highly heritable [42], the brains of unaffected first-
degree relatives offer an opportunity to identify familial
vulnerability markers or imaging endophenotypes for
psychiatric disorder. We recently used this strategy in
50 sibling pairs, of whom one was dependent on stimulant
drugs while the other had no history of chronic drug
abuse, and a group of unrelated healthy control volunteers
[37]. We found abnormally increased gray matter volume
in subcortical regions such as the amygdala, hippocampus
and putamen in both members of the sibling pairs,
suggesting that these abnormalities predated drug-taking
in the dependent individuals (Figure 2b and c). A sig-
nificant reduction of gray matter in the prefrontal cortex,
specifically in the orbitofrontal cortex and anterior insula,
was unique to the dependent group, with the changes in
orbitofrontal volume directly relating to the duration of
cocaine exposure.
We have also studied a group of recreational cocaine users
who had no family history of dependence but had been
using cocaine on a regular basis without making the
transition to dependence. As shown in Figure 2a, this
recreational user group did not show any structural endo-
phenotypic markers of increased risk as seen in the sibling
pairs, but instead showed increased gray matter volume in
the orbitofrontal cortex, anterior cingulate and insula [43],
suggesting a substrate of resilience against addiction.
These data indicate that inter-individual differences in
brain systems underlie a person’s risk for developing
stimulant dependence. In other words, the use of the
same drug may have different effects depending on the
individuals’ neurobiological vulnerability profile. As weCurrent Opinion in Neurobiology 2013, 23:615–624 did not study the first-degree relatives of the recreational
cocaine users, we can only speculate about the nature of
their potential resilience. Future studies are warranted to
clarify whether vulnerability and resilience represent the
extreme ends of a continuum for the risk to develop
addiction, or whether these are separate constructs
[44,45].
How specific are the structural brain
abnormalities for stimulant drug dependence?
Our meta-analysis identified significant structural
abnormalities in prefrontal brain regions extending to
the insula and pregenual anterior cingulate cortex. A
similar neuropathology, specifically in the anterior cingu-
late in conjunction with the insula, has recently been
identified by meta-analyses in other psychiatric disorders,
including bipolar disorder [46,47] and schizophrenia
[48,49,50]. Substance abuse is common in these psychia-
tric disorders [51], and it is conceivable that this shared
neuropathology of abnormal prefrontal structures, which
has been associated with dysfunction in self-regulation
and self-awareness [21], reflects an increase in vulner-
ability for stimulant drug dependence in these patient
populations. By contrast, familial vulnerability for stimu-
lant drug dependence, as seen in the first-degree relatives
of stimulant-dependent individuals, seems to be associ-
ated with subcortical abnormalities such as the enlarge-
ment of the putamen [37] and compulsive traits [52,53],
resembling the neuroimaging and cognitive abnormalities
associated with obsessive–compulsive disorder [19,54].
Both vulnerability-related changes, that is, the gray mat-
ter decrease in the anterior cingulate and insula cortex
and the increase of subcortical structures, specifically the
putamen, may mediate different kinds of behavioral
vulnerabilities, which need to be targeted differentially
by specific preventative strategies.
One psychiatric disorder frequently discussed with regard
to risk for addiction is attention deficit hyperactivity
disorder (ADHD) [55]. Both disorders, stimulant drug
dependence and ADHD, are associated with a highly
impulsive phenotype that increases the vulnerability for
recreational drug use to develop into drug addiction [56].
Despite the shared impulsive phenotype, the neuro-
pathology of these two disorders is distinctly different:
In contrast to stimulant drug dependence, ADHD has
been robustly associated with a decrease in basal ganglia
volume [36,57,58], which seems to normalize with pro-
gressing age and prolonged stimulant medication [36].
Moreover, ADHD has not been associated with compul-
sive traits, which may explain why methylphenidate,
which is pharmacologically similar to cocaine [59], is
not compulsively abused by patients with ADHD [60].
Taken together, stimulant drug dependence is associated
with a distinctive neuroanatomical profile, which overlaps
partly with neuropathological changes that have also been
associated with other psychiatric disorders.www.sciencedirect.com
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Figure 2
(a)
-36
(b)
Recreational
cocaine users
versus controls
Unaffected siblings of
dependent individuals 
versus controls
Stimulant-dependent
individuals
versus controls
(c)
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Current Opinion in Neurobiology
Structural abnormalities associated with (a) recreational stimulant exposure, (b) familial risk (first-degree relatives of stimulant-dependent individuals),
and (c) stimulant drug dependence. Blue voxels indicate a decrease and red voxels indicate an increase in gray matter volume compared with controls.
Both recreational and dependent stimulant users showed significant increase in the parahippocampal gyrus compared with healthy control volunteers
but differed with regard to abnormalities in the orbitofrontal cortex. Recreational users did not show any of the changes in brain regions associated
with familial risk such as increased volume of amygdala, putamen and decreased volume in posterior insula.
Reprinted with permission from Biological Psychiatry.Conclusion
Although the number of structural neuroimaging studies
in stimulant drug dependence has been growing steadily
over the past decade, their impact on clinical practice for
the treatment of stimulant-dependent individuals haswww.sciencedirect.com been limited. We used a voxel-wise meta-analysis
approach to identify a number of structural abnormalities
in the prefrontal cortex most robustly associated with
stimulant drug dependence, including the ventromedial
cortex, anterior cingulate gyrus, right inferior frontalCurrent Opinion in Neurobiology 2013, 23:615–624
622 Addictioncortex and insula. Similar brain abnormalities have also
frequently been reported in patients with psychotic dis-
orders, suggesting that a behavioral and emotional phe-
notype characterized by insufficient regulatory control
may be an underlying, if not a sufficient, component of
addiction vulnerability. Prolonged abuse of stimulant
drugs seems to exacerbate this pathology. By contrast,
familial vulnerability for addiction has been shown to
involve abnormalities in limbic-striatal structures (i.e.,
putamen, amygdala, and hippocampus) associated with
habit learning and compulsivity. Whether these distinct
pathologies require separate therapeutic interventions
needs to be determined by future studies. Neuroimaging
has the potential to provide new insight into complex
psychiatric conditions, opening up new avenues for diag-
nosis and treatments that lie beyond the scope of the
classical clinical phenotype.
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